Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1

PaperCitations, authors & open-access status

Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 33 citations, 2021 year and hybrid oa status.

33
Citations
2021
Year
hybrid
OA Status

Related on ScholarIQ

Joseph Panoff
Author
Neuroblastoma Research and Treatments
Topic
Neuroblastoma Research and Treatments
Topic
Cancer, Hypoxia, and Metabolism
Topic
Cancer therapeutics and mechanisms
Topic
470M+ articles · free account